FDA clears Think Surgical miniature robotic system for use with Mobio knee system implants
Click Here to Manage Email Alerts
Key takeaways:
- Think Surgical and b-One Ortho Corporation reached a collaboration agreement for a robotic knee surgery solution.
- The FDA approved the Think Surgical TMINI robotic system for use with Mobio knee system implants.
Think Surgical Inc. announced it received FDA 510(k) clearance for its TMINI miniature robotic total knee arthroplasty system to be used with Mobio total knee system implants from b-One Ortho Corporation, according to a press release.
“Think Surgical is excited to add the Mobio total knee system to the TMINI system,” Stuart Simpson, president and CEO of Think Surgical, said in the release. “The open platform version of TMINI is now available with eight different knee designs from eight separate orthopedic companies offering surgeons the choice of single-radius, anatomic and guided-motion knees on a single robotic platform.”
Think Surgical reached a collaboration agreement with b-One Ortho Corporation to allow Mobio knee system implants to be added to the TMINI miniature robotic platform, according to the release.
“We are enthusiastic about receiving this clearance for use with the Think Surgical TMINI system platform, which not only enhances our Mobio total knee system portfolio in offering our customers a robotic-assisted technology solution, but it also provides b-One greater market-penetrating strategic options and solutions,” Jim Duncan, general manager of b-One Ortho Corporation, said in the release. “We look forward to this continued partnership with Think Surgical offering a proven total knee design that can provide a smooth transition for many surgeons across the United States.”